|
| |
BiologicsBiologics is a specialty oncology pharmacy thoughtfully changing the way cancer drugs are dispensed to cancer patients through its Specialty Pharmacy; Clinical Trial Drug Management; Wholesale; Pharmaceutical Product Launch; and Veterinary services.
Founded in 1994, Biologics has carved a niche for itself in the $16 billion* specialty pharmacy industry as the first and only specialty pharmacy to dispense only oncology drugs. Biologics stocks only drugs that are currently used to treat cancer or are prescribed as supportive medications to I.V.-administered chemotherapy including subcutaneously injected, oral chemotherapeutic and anti-emetic drugs.
These specialty drugs require a high level of pharmaceutical expertise as they have unique storage, handling and dispensing standards. Biologics accompanies its exceptional pharmacy service with a dose of patient advocacy including insurance and Medicare filing, customized dispensing and packaging, on-time home delivery, and clinical monitoring for compliance and side effects. Privately held, Biologics is located in Raleigh, N.C
| Contact Details: |
| 625 Oberlin RoadPO Box 10568 |
| Raleigh |
| North Carolina |
| 27605 |
| United States of America |
| Tel: | 919-546-9810 |
| Fax: | 919-546-9816 |
| Email: | info@biologicstoday.com |
| WWW: | www.biologicstoday.com/
|
|
Loading...
|
Recent Publications by Biologics: |  |
A Live Attenuated H1N1 M1 Mutant Provides Broad Cross-Protection against Influenza A Viruses, Including Highly Pathogenic A/Vietnam/1203/2004, in Mice.
The emergence of novel influenza A H1N1 and highly pathogenic avian... | 17th November, 2009
| Laboratory of Respiratory Viral Diseases, Division of Viral Products,
| J Infect Dis. 2009 Dec 15;200(12):1874-1883.
DOI Direct Link |
Hemoglobin-based oxygen carriers: current status and future directions.
BACKGROUND: Hepatitis A virus (HAV), an atypical Picornaviridae that... | 17th November, 2009
| Office of Blood Research and Review, Center for Biologics Evaluation and
| Anesthesiology. 2009 Nov;111(5):946-63.
DOI Direct Link |
Phenylalanines at positions 88 and 159 of Ebolavirus envelope glycoprotein differentially impact envelope function.
The envelope glycoprotein (GP) of Ebolavirus (EBOV) mediates viral entry... | 13th November, 2009
| Division of Cellular and Gene Therapies, Center for Biologics Evaluation
| Virology. 2009 Nov 9.
DOI Direct Link |
Rapid online proteolytic mapping of PEGylated rhGH for identity confirmation, quantitation of methionine oxidation and quantitation of UnPEGylated N-terminus using HPLC with UV detection.
Proteolytic mapping is a widely used tool in the BioPharmaceutical... | 10th November, 2009
| Pfizer Global Biologics Pharmaceutical Sciences, Analytical Research and
| J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):4065-70.
DOI Direct Link |
Discovery and development of biopharmaceuticals: current issues.
The establishment of recombinant DNA technologies in the past several... | 10th November, 2009
| Biologics Research, Centocor R&D, Inc., Mailstop RA-2-4, 145 King of
| Curr Opin Biotechnol. 2009 Nov 5.
DOI Direct Link |
→View more Biologics research publications. |
Press Releases on Biologics:
|
 |
| Reportlinker Adds Cell/Tissue Culture Supplies - A Global Market Perspective |
25th November, 2009 |
Reportlinker |
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Cell/Tissue Culture Supplies - A Global Market Perspective
http://www
|
| Reportlinker Adds Veterinary Vaccines - A World Market Analysis |
25th November, 2009 |
Reportlinker |
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Veterinary Vaccines - A World Market Analysis
http://www.reportlinker.com
|
| Reportlinker Adds Probiotics - A Global Update of Market Trends & Opportunities |
25th November, 2009 |
Reportlinker |
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Probiotics - A Global Update of Market Trends & Opportunities
http:/
|
| Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients |
23rd November, 2009 |
Proteon Therapeutics, Inc. |
WALTHAM, Mass., Nov. 23 /PRNewswire/ -- Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease (ESRD) patients undergoing
|
| Dendreon Receives FDA Acknowledgement of Complete Response |
20th November, 2009 |
Dendreon Corporation |
SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 477 individuals from Biologics using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 557 times since April 2007, the link to the organisation's website has been followed 72 times Recent Search Terms used to find this page: Biologics, Cary NC | biologics pharmacy | biologics phar. nc | biologics pharmacy | pfizer biologics oncology drugs | biologics cary nc | Pharmacy biologicals | biologics to treat wound care 2009 | biologics pharmacy | List biologic oncology companies | . Search for more companies in Raleigh Search for more companies in North Carolina This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Biologics |
